Skip to main content
Premium Trial:

Request an Annual Quote

DOE Launches Network to Connect Six Bay Area Research Center to Supercomputer

NEW YORK, June 24 (GenomeWeb News) - The US Department of Energy's Office of Science launched a new network today that connects one of the DOE's most powerful supercomputers to six DOE sites in the San Francisco Bay Area, the DOE said.


According to the DOE, the new network will result in a decrease in annual networking costs for the DOE sites from $1.5 million to $500,000.


The six DOE sites  research climate change, genetics, renewable energy, nanotechnology, national security and basic science in physics and chemistry. They are: the StanfordLinearAcceleratorCenter, Lawrence Berkeley National Laboratory, the Joint Genome Institute, the NationalEnergyResearchScientificComputingCenter, Lawrence Livermore National Laboratory, and Sandia National Laboratories/Calfiornia.


The new Metropolitan Area Network will provide dual connectivity at 20 to 30 gigabytes per second, which is from 10 to 50 times the current site bandwidths, depending on the site.


The sites are being connected to the network in stages. Connection started with the Stanford Linear Accelerator Center, Lawrence Livermore National Laboratory, and Sandia in early June, and continued today with the NationalEnergyResearchScientificComputingCenter. All sites are scheduled to be connected by September.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.